Endothelin-A-receptor antagonist and oral prostacyclin analog are comparably effective in ameliorating pulmonary hypertension and right ventricular hypertrophy in rats

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5 SUPPL. 1, 2000, Pages

  Ueno, M ^a   Miyauchi, T ^a   Sakai, S ^a   Goto, K ^a   Yamaguchi, I ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelin A (ET(A)) receptor antagonist; Prostacyclin analog; Pulmonary hypertension (PH); Right ventricular hypertrophy

Indexed keywords

BERAPROST; BIOCHEMICAL MARKER; ENDOTHELIN A RECEPTOR ANTAGONIST; MESSENGER RNA; MONOCROTALINE; MYOSIN HEAVY CHAIN; N [6 [2 (5 BROMO 2 PYRIMIDINYLOXY)ETHOXY] 5 (4 METHYLPHENYL) 4 PYRIMIDINYL] 4 (2 HYDROXY 1,1 DIMETHYLETHYL)BENZENESULFONAMIDE; PROSTACYCLIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE CONTRACTION; HEART WEIGHT; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0033744355     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00012     Document Type: Article

References (30)

1. Primary pulmonary hypertension
2. Primary pulmonary hypertension: Natural history and the importance of thrombosis
3. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
4. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
5. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension
6. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species
7. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
8. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes
9. Molecular biology and biochemistry of the endothelins
10. Molecular and cellular mechanism of endothelin regulation: Implications for vascular function
11. Pathophysiology of endothelin in the cardiovascular system
12. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
13. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: Increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function
14. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload
15. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension
16. Pharmacological profile of T-0201, a highly potent and orally active endothelin receptor antagonist
17. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: A cross-sectional echocardiographic study
18. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: Marked increase in endothelin-1 production in the failing heart
19. Altered expression of isoform of myosin heavy chain mRNA in the failing rat heart is ameliorated by chronic treatment with an endothelin receptor antagonist
20. Complete nucleotide sequence of full length cDNA for rat beta cardiac myosin heavy chain
21. The role of endothelium in cardiovascular homeostasis and diseases
22. An imbalance between the excretion of thromboxane and prostacyclin metabolite in pulmonary hypertension
23. Prostacyclin and prostagrandin E1 for severe idiopathic pulmonary artery hypertension
24. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
25. Prostacyclin (epoprostenol) and heart-lung transplantation as treatment for severe pulmonary hypertension
26. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria
27. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide
28. Endothelin produces pulmonary vasoconstriction and systemic vasodilation
29. Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension
30. The role of thrombosis in severe pulmonary hypertension